|1.||Scheppach, W: 2 articles (12/2009 - 10/2005)|
|2.||Theis, S: 2 articles (12/2009 - 10/2005)|
|3.||Schauber, J: 2 articles (12/2009 - 10/2005)|
|4.||Melcher, R: 2 articles (12/2009 - 10/2005)|
|5.||Gostner, A: 2 articles (12/2009 - 10/2005)|
|6.||Mansueto, Pasquale: 1 article (10/2015)|
|7.||Seidita, Aurelio: 1 article (10/2015)|
|8.||Carroccio, Antonio: 1 article (10/2015)|
|9.||D'Alcamo, Alberto: 1 article (10/2015)|
|10.||Isik, U: 1 article (04/2011)|
|1.||Type 2 Diabetes Mellitus (MODY)
01/01/1996 - "A reduction in isomalt to 30 g was marked by increased tolerance with evidence of only mild borborygms (P <0.01), mild flatulence, colic, and laxation (P <0.05), with no increase in motion frequency (P <0.35). "
03/01/1992 - "In a double-blind crossover trial isomalt chocolate was associated in healthy consumers (n = 58) with increased motion frequency, wind and flatulence compared with sucrose chocolate. "
03/01/1992 - "Both isomalt and sorbitol chocolate were associated with higher incidence of wind and flatulence than for no chocolate, but only sorbitol chocolate increased motion frequency. "
01/01/1996 - "Ingestion of 40 g maltitol caused less intolerance than 40 g isomalt, with evidence of only flatulence, borborygms and colic (P <0.01), symptoms being rated as only mild. "
|3.||Body Weight (Weight, Body)
09/01/1994 - "The experiments were conducted using different amounts of Palatinit (300 and 1,200 mg/kg body weight = mg/kg b.w.). "
04/01/1990 - "Body weights of rats and mice fed 10% isomalt were generally slightly lower than those of controls. "
10/01/1989 - "In the females of the Bay FB:30 rats, a decreased body-weight gain and food consumption were observed in the 5 and 10% isomalt group. "
|5.||Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
10/01/2015 - "We reviewed literature, consulting PubMed and Medline by using the search terms FODMAP(s), fructose, lactose, fructans, galactans, polyols (sorbitol, mannitol, maltitol, xylitol, erythritol, polydextrose, and isomalt), irritable bowel syndrome, and functional gastrointestinal symptoms. "